Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 522
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06086197 | A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL | ||
| NCT04668508 | Anlotinib to Malignant Brainstem Glioma | ||
| NCT07035808 | a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer . | ||
| NCT05617469 | DLCS for Predicting Neoadjuvant Chemotherapy Response | ||
| NCT06220630 | The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study | ||
| NCT05273944 | Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients | ||
| NCT04084158 | A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. | ||
| NCT05030519 | A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer | ||
| NCT05075512 | The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer | ||
| NCT04421469 | Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC | ||
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | ||
| NCT05480189 | Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study | ||
| NCT06610799 | Study of IBI363 in Patients with Advanced First-line Gastric Cancer | ||
| NCT06350162 | Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC | ||
| NCT06478030 | Combined Screening for Gastrointestinal Tumors | ||
| NCT05468671 | Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy | ||
| NCT04711434 | PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients | ||
| NCT01285219 | A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy | ||
| NCT02448979 | Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach | ||
| NCT07271823 | Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer | ||
| NCT03647514 | Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer | ||
| NCT07014410 | Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer | ||
| NCT05124704 | Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia | ||
| NCT05550090 | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC | ||
| NCT05126160 | Immune Score Based Radiomics in Nasopharyngeal Carcinoma | ||
| NCT06031597 | Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy | ||
| NCT06133088 | Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. | ||
| NCT04135781 | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | ||
| NCT04981665 | A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection | ||
| NCT05652192 | SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC | ||
| NCT02481661 | Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC | ||
| NCT02518191 | Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity | ||
| NCT04140552 | Chinese Research Group of Gallbladder Cancer | ||
| NCT06022978 | Submucosal Saline Injection Followed by Endoscopic Ultrasound | ||
| NCT06374901 | Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment. | ||
| NCT05651802 | PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients | ||
| NCT01635400 | Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer | ||
| NCT07405346 | A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy | ||
| NCT01611766 | Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? | ||
| NCT06303583 | Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma | ||
| NCT07253194 | Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer | ||
| NCT05248022 | Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure | ||
| NCT04190745 | Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study | ||
| NCT06254066 | Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer | ||
| NCT02663440 | Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT07330544 | A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy | ||
| NCT07235930 | Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer | ||
| NCT04300959 | Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer | ||
| NCT05972460 | IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors | ||
| NCT03637634 | The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study |
